(2000) Idiopathic pulmonary fibrosis:diagnosis and treatment,

(2002) International multidisciꠀplinary consensus classification of idiopathic interstitial pneumonias: general principles and recommendations,

(2000) 통상성 간질성 폐섬유증의 임상경과,

(2003) 특발성 폐섬유화증의 치료,

(2001) Idiopathic pulmonary fibrosis: prevailing and evolving hypothesis about its pathogenesis and impliꠀcation for therapy,

(2001) Idiopathic pulꠀmonary fibrosis,

(1995) Molecular meꠀchanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression,

(2001) Molecular mechanisms of TGF-(beta) antagonism by interferon (gamma) and cyclosporine A in lung fibroblasts,

(1995) Increased expression of type VI collagen in lung fibrosis,

(1992) In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases,

(1996) Therapy of chronic interstitial lung disease with a combination of interꠀferon-γ and low-dose prednisolone,

(1999) A preliminary study of long- term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis,

(1990) Cytokine networks in the regulation of inflammation and fibrosis in the lung,

(1999) Tissue cytokine profiles of cryptogenic fibrosing alveolitis (CFA) and fibrosing alveolitis asꠀsociated with systemic sclerosis (FASSc) are distinct: a quantitative in situ study of open lung biopsies,

(1992) In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases,

(2003) A dark side of interferone- gamma in the treatment of pulmonary fibroꠀsis,

(2003) Acute Respiratory Failure after Interferon-γ Therapy of End-Stage Pulmonary Fibrosis,

(1997) Role of recombinant interferon-gamma mainꠀtenance in responding patients with small cell lung cancer, a randomized phase III study. Role of recombinant interferon-gamma mainꠀtenance in responding patients with small cell lung cancer, a randomized phase III study,

(jclinoncol1990) A phase I trial of recombinant interferon-gamma combined with recombinant interleukin-2 in patients with cancer,

(1995) Pilot study of human recombinant interferon gamma and acceleꠀ rated hyper fractionated thoracic radiation therapy in patients with unresectable stage IIIA/B nonsmall cell lung cancer,